Forward Citations = 1

Loading Chart...

9 inventors (with patents filed for the assignee):

Torrey Smith (5 out of 18 patents)

Daniel Alex Luebke (5 out of 7 patents)

Daniel V Moyer (5 out of 5 patents)

4. James G Erd (5 out of 5 patents)

5. Benjamin J Bonnes (3 out of 3 patents)

6. Kian L Tuma (2 out of 2 patents)

7. Rachel Natasha New (2 out of 3 patents)

8. William J Buxton (2 out of 2 patents)

9. Marcus X Luebke (2 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12201279 - Ingestible device with propulsion and imaging capabilities (2025-01-21),

2. 12059134 - Ingestible device with manipulation capabilities (2024-08-13),

3. 11986173 - Ingestible device with propulsion capabilities (2024-05-21),

4. 11622754 - Ingestible device with propulsion and imaging capabilities (2023-04-11),

5. 11045080 - Ingestible device with propulsion capabilities (2021-06-29),

Company Overview

Endiatx, Inc. is a biopharmaceutical company focused on developing novel cancer therapies. With a strong pipeline of targeted therapies, Endiatx is dedicated to bringing innovative treatments to patients in need. Through cutting-edge research and strategic partnerships, Endiatx aims to revolutionize cancer treatment and improve outcomes for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#91 in Hayward, CA

#12,070 in California

#51,620 in US

Hayward, CA, United States of America

Endiatx, Inc.

Forward Citations = 1

9 inventors:

Torrey Smith (5 out of 18 patents)

Daniel Alex Luebke (5 out of 7 patents)

Daniel V Moyer (5 out of 5 patents)

4. James G Erd (5 out of 5 patents)

5. Benjamin J Bonnes (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Endiatx, Inc.. Retrieved from https://idiyas.com/company/endiatx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]